$6.47
-0.16-2.34%
À la clôture: Nov 16, 4:00 PM EST

The average analyst price target for Satellos Bioscience is $21.25, 208.9% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $18 to $24. The latest change came on Oct 8, 2026, when Craig-Hallum initiated coverage of Satellos Bioscience with a Buy rating and a $24 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months